Epigenetic regulation of Keap1-Nrf2 signaling

Free Radical Biology and Medicine

Volumn 88, Issue Part B, 2015, Pages 337-349

  Guo, Yue ^a   Yu, Siwang ^b   Zhang, Chengyue ^a   Kong, Ah Ng Tony ^a  

^a RUTGERS UNIVERSITY   (United States)

^b PEKING UNIVERSITY   (China)

Author keywords

DNA methylation; Epigenetic; Histone modification; Keap1; MicroRNAs; Nrf2

Indexed keywords

HISTONE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MICRORNA; TRANSCRIPTION FACTOR NRF2; SIGNAL PEPTIDE;

ARTICLE; CELL PROTECTION; CHRONIC DISEASE; DNA METHYLATION; DNA SEQUENCE; ELECTROPHILIC STRESS; EPIGENETICS; GENE EXPRESSION; HISTONE MODIFICATION; HUMAN; INTRACELLULAR SIGNALING; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; ANIMAL; GENETIC EPIGENESIS; GENETICS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; EPIGENESIS, GENETIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84969902466     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.06.013     Document Type: Review

References (124)

1. K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J.D. Engel, and M. Yamamoto Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain Genes Dev 13 1999 76 86
2. N. Wakabayashi, S.L. Slocum, J.J. Skoko, S. Shin, and T.W. Kensler When Nrf2 talks, who's listening? Antioxidants & redox signaling 13 2010 1649 1663
3. W.S. Jeong, M. Jun, and A.N. Kong Nrf2: a potential molecular target for cancer chemoprevention by natural compounds Antioxidants & redox signaling 8 2006 99 106
4. J.D. Hayes, and M. McMahon Nrf2 and Keap1 mutations: permanent activation of an adaptive response in cancer Trends in biochemical sciences 34 2009 176 188
5. M.B. Sporn, and K.T. Liby Nrf2 and cancer: the good, the bad and the importance of context Nature reviews. Cancer 12 2012 564 571
6. X.J. Wang, Z. Sun, N.F. Villeneuve, S. Zhang, F. Zhao, Y. Li, W. Chen, X. Yi, W. Zheng, G.T. Wondrak, P.K. Wong, and D.D. Zhang Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2 Carcinogenesis 29 2008 1235 1243
7. A. Singh, V. Misra, R.K. Thimmulappa, H. Lee, S. Ames, M.O. Hoque, J.G. Herman, S.B. Baylin, D. Sidransky, E. Gabrielson, M.V. Brock, and S. Biswal Dysfunctional Keap1-Nrf2 interaction in non-small-cell lung cancer PLoS medicine 3 2006 e420
8. L.M. Solis, C. Behrens, W. Dong, M. Suraokar, N.C. Ozburn, C.A. Moran, A.H. Corvalan, S. Biswal, S.G. Swisher, B.N. Bekele, J.D. Minna, and D.J. Stewart Wistuba, II. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features Clinical cancer research: an official journal of the American Association for Cancer Research 16 2010 3743 3753
9. A.P. Wolffe, and M.A. Matzke Epigenetics: regulation through repression Science 286 1999 481 486
10. J.S. Mattick, and I.V. Makunin Non-coding RNA Human molecular genetics 15 2006 Spec No 1:R17-R29
11. E. Li Chromatin modification and epigenetic reprogramming in mammalian development Nature reviews. Genetics 3 2002 662 673
12. G. Egger, G. Liang, A. Aparicio, and P.A. Jones Epigenetics in human disease and prospects for epigenetic therapy Nature 429 2004 457 463
13. A.E. Teschendorff, J. West, and S. Beck Age-associated epigenetic drift: implications, and a case of epigenetic thrift? Human molecular genetics 22 2013 R7 R15
14. R. Feil, and M.F. Fraga Epigenetics and the environment: emerging patterns and implications Nature reviews. Genetics 13 2011 97 109
15. J. Sandoval, and M. Esteller Cancer epigenomics: beyond genomics Current opinion in genetics & development 22 2012 50 55
16. J.S. You, and P.A. Jones Cancer genetics and epigenetics: two sides of the same coin? Cancer cell 22 2012 9 20
17. M. Esteller Cancer epigenomics: DNA methylomes and histone-modification maps Nature reviews. Genetics 8 2007 286 298
18. A. Portela, and M. Esteller Epigenetic modifications and human disease Nature biotechnology 28 2010 1057 1068
19. C. Ling, and L. Groop Epigenetics: a molecular link between environmental factors and type 2 diabetes Diabetes 58 2009 2718 2725
20. D. Martino, D.A. Kesper, M. Amarasekera, H. Harb, H. Renz, and S. Prescott Epigenetics in immune development and in allergic and autoimmune diseases Journal of reproductive immunology 104-105 2014 43 48
21. D.E. Handy, R. Castro, and J. Loscalzo Epigenetic modifications: basic mechanisms and role in cardiovascular disease Circulation 123 2011 2145 2156
22. S.C. Marques, C.R. Oliveira, C.M. Pereira, and T.F. Outeiro Epigenetics in neurodegeneration: a new layer of complexity Progress in neuro-psychopharmacology & biological psychiatry 35 2011 348 355
23. K. Gronbaek, C. Hother, and P.A. Jones Epigenetic changes in cancer APMIS: acta pathologica, microbiologica, et immunologica Scandinavica 115 2007 1039 1059
24. D. Dhanak, and P. Jackson Development and classes of epigenetic drugs for cancer Biochemical and biophysical research communications 455 2014 58 69
25. Y. Guo, Z.-Y. Su, and A.-N.T. Kong Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal Phytochemicals Current Pharmacology Reports 2015 1 13
26. L. Shen, C.X. Song, C. He, and Y. Zhang Mechanism and function of oxidative reversal of DNA and RNA methylation Annual review of biochemistry 83 2014 585 614
27. R. Franco, O. Schoneveld, A.G. Georgakilas, and M.I. Panayiotidis Oxidative stress, DNA methylation and carcinogenesis Cancer letters 266 2008 6 11
28. Y. Niu, T.L. DesMarais, Z. Tong, Y. Yao, and M. Costa Oxidative stress alters global histone modification and DNA methylation Free radical biology & medicine 82 2015 22 28
29. Z.Y. Su, L. Shu, T.O. Khor, J.H. Lee, F. Fuentes, and A.N. Kong A perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomics Topics in current chemistry 329 2013 133 162
30. M. Tada, O. Yokosuka, K. Fukai, T. Chiba, F. Imazeki, T. Tokuhisa, and H. Saisho Hypermethylation of NAD(P)H: quinone oxidoreductase 1 (NQO1) gene in human hepatocellular carcinoma Journal of hepatology 42 2005 511 519
31. I. Meiers, J.H. Shanks, and D.G. Bostwick Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007 Pathology 39 2007 299 304
32. A.S. Belanger, J. Tojcic, M. Harvey, and C. Guillemette Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells BMC molecular biology 11 2010 9
33. P.A. Jones, and D. Takai The role of DNA methylation in mammalian epigenetics Science 293 2001 1068 1070
34. D. Schubeler Function and information content of DNA methylation Nature 517 2015 321 326
35. E. Li, and Y. Zhang DNA methylation in mammals Cold Spring Harbor perspectives in biology 6 2014 a019133
36. J.F. Gagnon, O. Bernard, L. Villeneuve, B. Tetu, and C. Guillemette Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer Clinical cancer research: an official journal of the American Association for Cancer Research 12 2006 1850 1858
37. E.M. Hurt, S.B. Thomas, B. Peng, and W.L. Farrar Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines British journal of cancer 97 2007 1116 1123
38. M.M. Mohamed, S. Sabet, D.F. Peng, M.A. Nouh, M. El-Shinawi, and W. El-Rifai Promoter hypermethylation and suppression of glutathione peroxidase 3 are associated with inflammatory breast carcinogenesis Oxidative medicine and cellular longevity 2014 2014 787195
39. C. Xu, M.T. Huang, G. Shen, X. Yuan, W. Lin, T.O. Khor, A.H. Conney, and A.N. Kong Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2 Cancer research 66 2006 8293 8296
40. A. Barve, T.O. Khor, S. Nair, K. Reuhl, N. Suh, B. Reddy, H. Newmark, and A.N. Kong Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice International journal of cancer. Journal international du cancer 124 2009 1693 1699
41. D.A. Frohlich, M.T. McCabe, R.S. Arnold, and M.L. Day The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis Oncogene 27 2008 4353 4362
42. S. Yu, T.O. Khor, K.L. Cheung, W. Li, T.Y. Wu, Y. Huang, B.A. Foster, Y.W. Kan, and A.N. Kong Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice PloS one 5 2010 e8579
43. T.O. Khor, F. Fuentes, L. Shu, X. Paredes-Gonzalez, A.Y. Yang, Y. Liu, D.J. Smiraglia, S. Yegnasubramanian, W.G. Nelson, and A.N. Kong Epigenetic DNA Methylation of Antioxidative Stress Regulator Nrf2 in Human Prostate Cancer Cancer prevention research 7 2014 1186 1197
44. Y. Huang, T.O. Khor, L. Shu, C.L. Saw, T.Y. Wu, N. Suh, C.S. Yang, and A.N. Kong A gamma-tocopherol-rich mixture of tocopherols maintains Nrf2 expression in prostate tumors of TRAMP mice via epigenetic inhibition of CpG methylation The Journal of nutrition 142 2012 818 823
45. Y. Guo, L. Shu, C. Zhang, Z.Y. Su, and A.N. Kong Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1 Biochemical pharmacology 94 2015 69 78
46. C. Gerhauser Epigenetic impact of dietary isothiocyanates in cancer chemoprevention Current opinion in clinical nutrition and metabolic care 16 2013 405 410
47. M.Z. Fang, Y. Wang, N. Ai, Z. Hou, Y. Sun, H. Lu, W. Welsh, and C.S. Yang Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines Cancer research 63 2003 7563 7570
48. Q. Xie, Q. Bai, L.Y. Zou, Q.Y. Zhang, Y. Zhou, H. Chang, L. Yi, J.D. Zhu, and M.T. Mi Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells Genes, chromosomes & cancer 53 2014 422 431
49. T.O. Khor, Y. Huang, T.Y. Wu, L. Shu, J. Lee, and A.N. Kong Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation Biochemical pharmacology 82 2011 1073 1078
50. T.Y. Wu, T.O. Khor, Z.Y. Su, C.L. Saw, L. Shu, K.L. Cheung, Y. Huang, S. Yu, and A.N. Kong Epigenetic modifications of Nrf2 by 3,3'-diindolylmethane in vitro in TRAMP C1 cell line and in vivo TRAMP prostate tumors The AAPS journal 15 2013 864 874
51. C. Zhang, Z.Y. Su, T.O. Khor, L. Shu, and A.N. Kong Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation Biochem Pharmacol 85 2013 1398 1404
52. Z.Y. Su, T.O. Khor, L. Shu, J.H. Lee, C.L. Saw, T.Y. Wu, Y. Huang, N. Suh, C.S. Yang, A.H. Conney, Q. Wu, and A.N. Kong Epigenetic reactivation of Nrf2 in murine prostate cancer TRAMP C1 cells by natural phytochemicals Z-ligustilide and Radix angelica sinensis via promoter CpG demethylation Chemical research in toxicology 26 2013 477 485
53. X. Paredes-Gonzalez, F. Fuentes, Z.Y. Su, and A.N. Kong Apigenin reactivates Nrf2 anti-oxidative stress signaling in mouse skin epidermal JB6 P+cells through epigenetics modifications The AAPS journal 16 2014 727 735
54. Z.Y. Su, C. Zhang, J.H. Lee, L. Shu, T.Y. Wu, T.O. Khor, A.H. Conney, Y.P. Lu, and A.N. Kong Requirement and epigenetics reprogramming of Nrf2 in suppression of tumor promoter TPA-induced mouse skin cell transformation by sulforaphane Cancer Prev Res (Phila) 7 2014 319 329
55. L. Wang, C. Zhang, Y. Guo, Z.Y. Su, Y. Yang, L. Shu, and A.N. Kong Blocking of JB6 cell transformation by tanshinone IIA: epigenetic reactivation of Nrf2 antioxidative stress pathway The AAPS journal 16 2014 1214 1225
56. R. Wang, J. An, F. Ji, H. Jiao, H. Sun, and D. Zhou Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues Biochemical and biophysical research communications 373 2008 151 154
57. D. Guo, B. Wu, J. Yan, X. Li, H. Sun, and D. Zhou A possible gene silencing mechanism: hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells Biochemical and biophysical research communications 428 2012 80 85
58. L.A. Muscarella, P. Parrella, V. D'Alessandro, A. la Torre, R. Barbano, A. Fontana, A. Tancredi, V. Guarnieri, T. Balsamo, M. Coco, M. Copetti, F. Pellegrini, P. De Bonis, M. Bisceglia, G. Scaramuzzi, E. Maiello, V.M. Valori, G. Merla, G. Vendemiale, and V.M. Fazio Frequent epigenetics inactivation of Keap1 gene in non-small cell lung cancer Epigenetics: official journal of the DNA Methylation Society 6 2011 710 719
59. L.A. Muscarella, R. Barbano, V. D'Angelo, M. Copetti, M. Coco, T. Balsamo, A. la Torre, A. Notarangelo, M. Troiano, S. Parisi, N. Icolaro, D. Catapano, V.M. Valori, F. Pellegrini, G. Merla, M. Carella, V.M. Fazio, and P. Parrella Regulation of Keap1 expression by promoter methylation in malignant gliomas and association with patient's outcome Epigenetics: official journal of the DNA Methylation Society 6 2011 317 325
60. R. Barbano, L.A. Muscarella, B. Pasculli, V.M. Valori, A. Fontana, M. Coco, A. la Torre, T. Balsamo, M.L. Poeta, G.F. Marangi, E. Maiello, M. Castelvetere, F. Pellegrini, R. Murgo, V.M. Fazio, and P. Parrella Aberrant Keap1 methylation in breast cancer and association with clinicopathological features Epigenetics: official journal of the DNA Methylation Society 8 2013 105 112
61. N. Hanada, T. Takahata, Q. Zhou, X. Ye, R. Sun, J. Itoh, A. Ishiguro, H. Kijima, J. Mimura, K. Itoh, S. Fukuda, and Y. Saijo Methylation of the Keap1 gene promoter region in human colorectal cancer BMC cancer 12 2012 66
62. A.R. Jazirehi, P.B. Wenn, and D. Arle Is there a decrease in Keap1 RNA expression in colorectal cancer cells, and is this decrease in expression due to hypermethylation? Epigenomics 4 2012 253 254
63. P. Zhang, A. Singh, S. Yegnasubramanian, D. Esopi, P. Kombairaju, M. Bodas, H. Wu, S.G. Bova, and S. Biswal Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth Molecular cancer therapeutics 9 2010 336 346
64. V.D. Martinez, E.A. Vucic, L.A. Pikor, K.L. Thu, R. Hubaux, and W.L. Lam Frequent concerted genetic mechanisms disrupt multiple components of the Nrf2 inhibitor Keap1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer Mol Cancer 12 2013 124
65. R. Elanchezhian, P. Palsamy, C.J. Madson, D.W. Lynch, and T. Shinohara Age-related cataracts: homocysteine coupled endoplasmic reticulum stress and suppression of Nrf2-dependent antioxidant protection Chemico-biological interactions 200 2012 1 10
66. M. von Otter, S. Landgren, S. Nilsson, M. Zetterberg, D. Celojevic, P. Bergstrom, L. Minthon, N. Bogdanovic, N. Andreasen, D.R. Gustafson, I. Skoog, A. Wallin, G. Tasa, K. Blennow, M. Nilsson, O. Hammarsten, and H. Zetterberg Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract Mechanisms of ageing and development 131 2010 105 110
67. P. Palsamy, M. Ayaki, R. Elanchezhian, and T. Shinohara Promoter demethylation of Keap1 gene in human diabetic cataractous lenses Biochemical and biophysical research communications 423 2012 542 548
68. Y. Gao, Y. Yan, and T. Huang Human agerelated cataracts: Epigenetic suppression of the nuclear factor erythroid 2related factor 2mediated antioxidant system Molecular medicine reports 11 2015 1442 1447
69. S.P. Yang, X.Z. Yang, and G.P. Cao Acetyllcarnitine prevents homocysteineinduced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells Molecular medicine reports 12 2015 1145 1150
70. P. Palsamy, K.R. Bidasee, and T. Shinohara Selenite cataracts: activation of endoplasmic reticulum stress and loss of Nrf2/Keap1-dependent stress protection Biochimica et biophysica acta 1794-1805 1842 2014
71. P. Palsamy, K.R. Bidasee, M. Ayaki, R.C. Augusteyn, J.Y. Chan, and T. Shinohara Methylglyoxal induces endoplasmic reticulum stress and DNA demethylation in the Keap1 promoter of human lens epithelial cells and age-related cataracts Free radical biology & medicine 72 2014 134 148
72. P. Palsamy, K.R. Bidasee, and T. Shinohara Valproic acid suppresses Nrf2/Keap1 dependent antioxidant protection through induction of endoplasmic reticulum stress and Keap1 promoter DNA demethylation in human lens epithelial cells Experimental eye research 121 2014 26 34
73. Z.Z. Liu, X.Z. Zhao, X.S. Zhang, and M. Zhang Promoter DNA demethylation of Keap1 gene in diabetic cardiomyopathy International journal of clinical and experimental pathology 7 2014 8756 8762
74. R.D. Kornberg, and Y. Lorch Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome Cell 98 1999 285 294
75. K.L. Huisinga, B. Brower-Toland, and S.C. Elgin The contradictory definitions of heterochromatin: transcription and silencing Chromosoma 115 2006 110 122
76. K. Ura, H. Kurumizaka, S. Dimitrov, G. Almouzni, and A.P. Wolffe Histone acetylation: influence on transcription, nucleosome mobility and positioning, and linker histone-dependent transcriptional repression The EMBO journal 16 1997 2096 2107
77. G.H. Liu, J. Qu, and X. Shen NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK Biochimica et biophysica acta 713-727 1783 2008
78. F. Correa, C. Mallard, M. Nilsson, and M. Sandberg Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3beta Neurobiology of disease 44 2011 142 151
79. B. Wang, X. Zhu, Y. Kim, J. Li, S. Huang, S. Saleem, R.C. Li, Y. Xu, S. Dore, and W. Cao Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage Free radical biology & medicine 52 2012 928 936
80. N. Mercado, R. Thimmulappa, C.M. Thomas, P.S. Fenwick, K.K. Chana, L.E. Donnelly, S. Biswal, K. Ito, and P.J. Barnes Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress Biochemical and biophysical research communications 406 2011 292 298
81. D. Adenuga, S. Caito, H. Yao, I.K. Sundar, J.W. Hwang, S. Chung, and I. Rahman Nrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reduction Biochemical and biophysical research communications 403 2010 452 456
82. H.C. Lam, S.M. Cloonan, A.R. Bhashyam, J.A. Haspel, A. Singh, J.F. Sathirapongsasuti, M. Cervo, H. Yao, A.L. Chung, K. Mizumura, C.H. An, B. Shan, J.M. Franks, K.J. Haley, C.A. Owen, Y. Tesfaigzi, G.R. Washko, J. Quackenbush, E.K. Silverman, I. Rahman, H.P. Kim, A. Mahmood, S.S. Biswal, S.W. Ryter, and A.M. Choi Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction The Journal of clinical investigation 123 2013 5212 5230
83. Y. Kawai, L. Garduno, M. Theodore, J. Yang, and I.J. Arinze Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization The Journal of biological chemistry 286 2011 7629 7640
84. Z. Sun, Y.E. Chin, and D.D. Zhang Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response Molecular and cellular biology 29 2009 2658 2672
85. Z. Chen, X. Ye, N. Tang, S. Shen, Z. Li, X. Niu, S. Lu, and L. Xu The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer British journal of pharmacology 171 2014 3196 3211
86. H. Ikeda, S. Nishi, and M. Sakai Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis The Biochemical journal 380 2004 515 521
87. K. Ohta, M. Ohigashi, A. Naganawa, H. Ikeda, M. Sakai, J. Nishikawa, M. Imagawa, S. Osada, and T. Nishihara Histone acetyltransferase MOZ acts as a co-activator of Nrf2-MafK and induces tumour marker gene expression during hepatocarcinogenesis The Biochemical journal 402 2007 559 566
88. S. Kalthoff, A. Winkler, N. Freiberg, M.P. Manns, and C.P. Strassburg Gender matters: estrogen receptor alpha (ERalpha) and histone deacetylase (HDAC) 1 and 2 control the gender-specific transcriptional regulation of human uridine diphosphate glucuronosyltransferases genes (UGT1A) Journal of hepatology 59 2013 797 804
89. E.L. Greer, and Y. Shi Histone methylation: a dynamic mark in health, disease and inheritance Nature reviews. Genetics 13 2012 343 357
90. A. Chase, and N.C. Cross Aberrations of EZH2 in cancer Clinical cancer research: an official journal of the American Association for Cancer Research 17 2011 2613 2618
91. A.J. Ruthenburg, C.D. Allis, and J. Wysocka Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark Molecular cell 25 2007 15 30
92. S. Balasubramanian, S. Kanade, B. Han, and R.L. Eckert A proteasome inhibitor-stimulated Nrf1 protein-dependent compensatory increase in proteasome subunit gene expression reduces polycomb group protein level The Journal of biological chemistry 287 2012 36179 36189
93. Z. Li, L. Xu, N. Tang, Y. Xu, X. Ye, S. Shen, X. Niu, S. Lu, and Z. Chen The polycomb group protein EZH2 inhibits lung cancer cell growth by repressing the transcription factor Nrf2 FEBS letters 588 2014 3000 3007
94. S.K. Knutson, S. Kawano, Y. Minoshima, N.M. Warholic, K.C. Huang, Y. Xiao, T. Kadowaki, M. Uesugi, G. Kuznetsov, N. Kumar, T.J. Wigle, C.R. Klaus, C.J. Allain, A. Raimondi, N.J. Waters, J.J. Smith, M. Porter-Scott, R. Chesworth, M.P. Moyer, R.A. Copeland, V.M. Richon, T. Uenaka, R.M. Pollock, K.W. Kuntz, A. Yokoi, and H. Keilhack Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma Molecular cancer therapeutics 13 2014 842 854
95. F. Crea, L. Fornaro, G. Bocci, L. Sun, W.L. Farrar, A. Falcone, and R. Danesi EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis Cancer metastasis reviews 31 2012 753 761
96. M. Mishra, Q. Zhong, and R.A. Kowluru Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathy Investigative ophthalmology & visual science 55 2014 7256 7265
97. Q. Zhong, and R.A. Kowluru Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation Investigative ophthalmology & visual science 54 2013 244 250
98. M. Mishra, Q. Zhong, and R.A. Kowluru Epigenetic modifications of Nrf2-mediated glutamate-cysteine ligase: implications for the development of diabetic retinopathy and the metabolic memory phenomenon associated with its continued progression Free radical biology & medicine 75 2014 129 139
99. M. Miranda, M. Muriach, S. Johnsen, F. Bosch-Morell, J. Araiz, J. Roma, and F.J. Romero [Oxidative stress in a model for experimental diabetic retinopathy: treatment with antioxidants] Archivos de la Sociedad Espanola de Oftalmologia 79 2004 289 294
100. T. Jenuwein, and C.D. Allis Translating the histone code Science 293 2001 1074 1080
101. R. Sanchez, and M.M. Zhou The role of human bromodomains in chromatin biology and gene transcription Current opinion in drug discovery & development 12 2009 659 665
102. S.Y. Wu, and C.M. Chiang The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation The Journal of biological chemistry 282 2007 13141 13145
103. C. Michaeloudes, N. Mercado, C. Clarke, P.K. Bhavsar, I.M. Adcock, P.J. Barnes, and K.F. Chung Bromodomain and extraterminal proteins suppress NF-E2-related factor 2-mediated antioxidant gene expression Journal of immunology 192 2014 4913 4920
104. M. Hussong, S.T. Borno, M. Kerick, A. Wunderlich, A. Franz, H. Sultmann, B. Timmermann, H. Lehrach, M. Hirsch-Kauffmann, and M.R. Schweiger The bromodomain protein BRD4 regulates the Keap1/Nrf2-dependent oxidative stress response Cell death & disease 5 2014 e1195
105. C. Sangokoya, M.J. Telen, and J.T. Chi microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease Blood 116 2010 4338 4348
106. M. Narasimhan, D. Patel, D. Vedpathak, M. Rathinam, G. Henderson, and L. Mahimainathan Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells PloS one 7 2012 e51111
107. J. Takamizawa, H. Konishi, K. Yanagisawa, S. Tomida, H. Osada, H. Endoh, T. Harano, Y. Yatabe, M. Nagino, Y. Nimura, T. Mitsudomi, and T. Takahashi Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival Cancer research 64 2004 3753 3756
108. A. Esquela-Kerscher, and F.J. Slack Oncomirs-microRNAs with a role in cancer Nature reviews. Cancer 6 2006 259 269
109. M. Yang, Y. Yao, G. Eades, Y. Zhang, and Q. Zhou MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism Breast cancer research and treatment 129 2011 983 991
110. B. Singh, A.M. Ronghe, A. Chatterjee, N.K. Bhat, and H.K. Bhat MicroRNA-93 regulates Nrf2 expression and is associated with breast carcinogenesis Carcinogenesis 34 2013 1165 1172
111. G. Eades, M. Yang, Y. Yao, Y. Zhang, and Q. Zhou miR-200 a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells The Journal of biological chemistry 286 2011 40725 40733
112. J.H. Kim, K.S. Lee, D.K. Lee, J. Kim, S.N. Kwak, K.S. Ha, J. Choe, M.H. Won, B.R. Cho, D. Jeoung, H. Lee, Y.G. Kwon, and Y.M. Kim Hypoxia-responsive microRNA-101 promotes angiogenesis via heme oxygenase-1/vascular endothelial growth factor axis by targeting cullin 3 Antioxidants & redox signaling 21 2014 2469 2482
113. J.F. Reichard, G.T. Motz, and A. Puga Heme oxygenase-1 induction by Nrf2 requires inactivation of the transcriptional repressor BACH1 Nucleic acids research 35 2007 7074 7086
114. A.K. MacLeod, M. McMahon, S.M. Plummer, L.G. Higgins, T.M. Penning, K. Igarashi, and J.D. Hayes Characterization of the cancer chemopreventive Nrf2-dependent gene battery in human keratinocytes: demonstration that the Keap1-Nrf2 pathway, and not the BACH1-Nrf2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds Carcinogenesis 30 2009 1571 1580
115. W. Hou, Q. Tian, N.M. Steuerwald, L.W. Schrum, and H.L. Bonkovsky The let-7 microRNA enhances heme oxygenase-1 by suppressing Bach1 and attenuates oxidant injury in human hepatocytes Biochimica et biophysica acta 1113-1122 1819 2012
116. K.H. Pulkkinen, S. Yla-Herttuala, and A.L. Levonen Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells Free radical biology & medicine 51 2011 2124 2131
117. A.E. Wagner, C. Boesch-Saadatmandi, J. Dose, G. Schultheiss, and G. Rimbach Anti-inflammatory potential of allyl-isothiocyanate - role of Nrf2, NF-(kappa) B and microRNA-155 Journal of cellular and molecular medicine 16 2012 836 843
118. N.M. Shah, S.A. Rushworth, M.Y. Murray, K.M. Bowles, and D.J. MacEwan Understanding the role of Nrf2-regulated miRNAs in human malignancies Oncotarget 4 2013 1130 1142
119. D. Papp, K. Lenti, D. Modos, D. Fazekas, Z. Dul, D. Turei, L. Foldvari-Nagy, R. Nussinov, P. Csermely, and T. Korcsmaros The Nrf2-related interactome and regulome contain multifunctional proteins and fine-tuned autoregulatory loops FEBS letters 586 2012 1795 1802
120. Y. Kondo Epigenetic cross-talk between DNA methylation and histone modifications in human cancers Yonsei medical journal 50 2009 455 463
121. T. Vaissiere, C. Sawan, and Z. Herceg Epigenetic interplay between histone modifications and DNA methylation in gene silencing Mutation research 659 2008 40 48
122. L. Vrba, T.J. Jensen, J.C. Garbe, R.L. Heimark, A.E. Cress, S. Dickinson, M.R. Stampfer, and B.W. Futscher Role for DNA methylation in the regulation of miR-200 c and miR-141 expression in normal and cancer cells PloS one 5 2010 e8697
123. G. Eades, Y. Yao, M. Yang, Y. Zhang, S. Chumsri, and Q. Zhou miR-200 a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells The Journal of biological chemistry 286 2011 25992 26002
124. T. Murray-Stewart, C.L. Hanigan, P.M. Woster, L.J. Marton, and R.A. Casero Jr. Histone deacetylase inhibition overcomes drug resistance through a miRNA-dependent mechanism Mol Cancer Ther 12 2013 2088 2099